Australia markets closed

Petros Pharmaceuticals, Inc. (PTPI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6503+0.0006 (+0.09%)
At close: 04:00PM EDT
0.6253 -0.03 (-3.84%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
4,327
5,822
5,992
7,811
9,559
-
Cost of revenue
1,652
1,631
2,289
1,600
4,046
-
Gross profit
2,675
4,191
3,703
6,212
5,513
-
Operating expenses
Research development
2,551
2,409
1,740
1,788
459.636
-
Selling general and administrative
13,467
9,261
12,209
15,593
15,675
-
Total operating expenses
22,393
14,954
19,548
24,260
22,795
-
Operating income or loss
-19,718
-10,762
-15,846
-18,048
-17,282
-
Interest expense
462.862
536.138
596.018
368.66
3,051
-
Total other income/expenses net
-3,820
2,620
-3,610
9,430
-1,680
-
Income before tax
-24,001
-8,163
-20,038
-8,987
-22,013
-
Income tax expense
1.456
0
0
0
-1,427
-
Income from continuing operations
-24,002
-8,163
-20,038
-8,987
-20,586
-
Net income
-24,002
-8,163
-20,038
-8,987
-20,586
-
Net income available to common shareholders
-24,002
-13,814
-20,038
-8,987
-20,586
-
Basic EPS
-6.21
-
-9.68
-8.25
-38.50
-33.49
Diluted EPS
-6.21
-
-9.68
-8.25
-38.50
-33.49
Basic average shares
2,100
-
2,070
1,089
534.068
970.774
Diluted average shares
2,100
-
2,070
1,089
534.068
970.774